Skip to Content

Advantis Corp ADVT Stock Quote

| Rating as of


Morningstar‘s Stock Analysis ADVT

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics ADVT

Company Profile ADVT

Business Description

Advantis Corp is a development stage company. It is pursuing business opportunities to the development of pharmaceutical grade CBD extractions, concentrates and medicines in Nevada, California, and Washington. The company is also establishing partnerships with businesses that develop and sell proprietary consumer products and services. It is developing a product line for the consumer, music, and entertainment sectors.

1048 Irvine boulevard, Suite 900
Newport Beach, CA, 92660
T +1 949 354-3585
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2000
Fiscal Year End Dec 31, 2012
Employees 12